Photodynamic therapy with topical methyl aminolevulinate for actinic keratosis in organ transplant recipients: Methods to improve treatment [Fotodynamisk terapi med topikal methyl-aminolevulinat til aktiniske keratoser hos organtransplanterede patienter: Metoder til at optimere behandling]
Latest Information Update: 19 Aug 2022
At a glance
- Drugs Methyl aminolevulinate (Primary)
- Indications Actinic keratosis; Skin cancer
- Focus Therapeutic Use
- 18 Aug 2022 Status changed from recruiting to completed.
- 30 Nov 2012 Planned number of patients changed from 19 to 15 as reported by European Clinical Trials Database record.
- 03 Aug 2012 New trial record